Endovascular treatmenT for Acute Ischemic Stroke in China
DETECT-China
1 other identifier
observational
1,000
1 country
1
Brief Summary
This is a retrospective real world registry study, aiming to explore the effectiveness and safety of endovascular treatment of acute ischemic stroke in a Chinese population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 10, 2021
CompletedFirst Posted
Study publicly available on registry
February 12, 2021
CompletedStudy Start
First participant enrolled
March 22, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 8, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
February 8, 2023
CompletedFebruary 10, 2023
February 1, 2023
1.9 years
February 10, 2021
February 8, 2023
Conditions
Outcome Measures
Primary Outcomes (1)
Proportion of patients with modified Rankin Score (mRS) 0 to 2
the minimum and maximum values of mRS are 0 and 6, respectively; higher mRS mean a worse outcome
Day 90
Secondary Outcomes (7)
Changes in National Institute of Health stroke scale (NIHSS)
Day 2, 7, 14
Proportion of patients with modified Rankin Score 0 to 2
Day180, 360
Distribution of modified Rankin Score
Day 90, 180, 360
Proportion of symptomatic intracranial hemorrhage (sICH)
48 hours
Proportion of intraparenchymal hemorrhage (PH1 and PH2)
48 hours
- +2 more secondary outcomes
Interventions
all enrolled patients must receive endovascular treatment.
Eligibility Criteria
all patients must receive endovascular treatment regardless of the time from onset to treatment.
You may qualify if:
- Age: ≥ 18;
- Ischemic stroke confirmed by head CT or MRI;
- Patients receiving endovascular treatment;
- First ever stroke or mRS≤2 after previous disease;
- Complete and clear pre- and post-operative DSA images are available
You may not qualify if:
- Imaging data not qualified for evaluation;
- Absence of important clinical data;
- The first 50 patients receiving endovascular treatment in a single centerr.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Neurology, General Hospital of Northern Theater Command
Shenyang, 110016, China
Related Publications (1)
Xing GP, Li W, Cui C, Zhao ZA, Nguyen TN, Chen HS. Thrombolysis to Recanalization Time Affects the Benefit of Bridging Thrombolysis in Large Vessel Occlusion Patients With Successful Recanalization. CNS Neurosci Ther. 2025 Sep;31(9):e70579. doi: 10.1111/cns.70579.
PMID: 40947819DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Neurology
Study Record Dates
First Submitted
February 10, 2021
First Posted
February 12, 2021
Study Start
March 22, 2021
Primary Completion
February 8, 2023
Study Completion
February 8, 2023
Last Updated
February 10, 2023
Record last verified: 2023-02